Suppr超能文献

2型糖尿病合并脂肪肝患者肝脏瞬时弹性成像检查结果严重程度的相关因素

Factors associated with the Severity of Findings on Hepatic Transient Elastography among Persons with Type 2 Diabetes and Fatty Liver.

作者信息

Fernando Joseph Noel, Alba Rebecca Lim, Alba Willy

机构信息

Section of Endocrinology, Diabetes and Metabolism, Chinese General Hospital and Medical Center, Philippines.

Section of Gastroenterology, Chinese General Hospital and Medical Center, Philippines.

出版信息

J ASEAN Fed Endocr Soc. 2019;34(2):134-143. doi: 10.15605/jafes.034.02.03. Epub 2019 Nov 10.

Abstract

OBJECTIVE

This study aims to determine the relationship between the different factors associated with the severity of findings among patients with Type 2 diabetes and fatty liver.

METHODOLOGY

This is a cross-sectional study. Seven hundred four results were electronically retrieved from a diagnostic center. 285 charts of diabetic patients with fatty liver on ultrasound were reviewed. 164 patients with fatty liver on ultrasound and were included in the study. Several factors were analysed in relation to the severity of findings in the study group.

RESULTS

Fifty five point five percent (55.5%) (91/164) had significant fibrosis and cirrhosis. Hepatic steatosis prevalence was 96% (158/164). Diabetes >5 years (OR 1.75), HbA1c >7% (OR 2.25) and high SGPT levels (OR 2.39) were associated with liver fibrosis and cirrhosis. BMI >25 kg/m2 (OR 1.45), triglyceride levels >150 mg/dl (OR 1.31) and HbA1c >7% (OR 1.74) were associated with hepatic steatosis.

CONCLUSION

Factors associated with the severity of hepatic fibrosis, cirrhosis and steatosis included above normal BMI, disease duration of >5 years, poor glycemic control and elevated levels of ALT, and serum triglycerides.

摘要

目的

本研究旨在确定2型糖尿病合并脂肪肝患者中不同因素与检查结果严重程度之间的关系。

方法

这是一项横断面研究。从一个诊断中心电子检索到704份结果。对285例超声检查显示有脂肪肝的糖尿病患者的病历进行了回顾。164例超声检查显示有脂肪肝的患者被纳入研究。分析了与研究组检查结果严重程度相关的几个因素。

结果

55.5%(91/164)有显著纤维化和肝硬化。肝脂肪变性患病率为96%(158/164)。糖尿病病程>5年(比值比1.75)、糖化血红蛋白>7%(比值比2.25)和谷丙转氨酶水平高(比值比2.39)与肝纤维化和肝硬化相关。体重指数>25kg/m²(比值比1.45)、甘油三酯水平>150mg/dl(比值比1.31)和糖化血红蛋白>7%(比值比1.74)与肝脂肪变性相关。

结论

与肝纤维化、肝硬化和脂肪变性严重程度相关的因素包括体重指数高于正常、病程>5年、血糖控制不佳以及谷丙转氨酶和血清甘油三酯水平升高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f78a/7784217/44e3a7146e0c/JAFES-34-2-134-g001.jpg

相似文献

1
Factors associated with the Severity of Findings on Hepatic Transient Elastography among Persons with Type 2 Diabetes and Fatty Liver.
J ASEAN Fed Endocr Soc. 2019;34(2):134-143. doi: 10.15605/jafes.034.02.03. Epub 2019 Nov 10.
9
High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus.
Clin Nutr ESPEN. 2021 Dec;46:519-526. doi: 10.1016/j.clnesp.2021.08.028. Epub 2021 Sep 6.

引用本文的文献

1
Prevalence and associated factors of MAFLD in adults with type 2 diabetes.
PLOS Glob Public Health. 2024 Dec 30;4(12):e0003572. doi: 10.1371/journal.pgph.0003572. eCollection 2024.
3
Improved glycaemic control in patients with type 2 diabetes has a beneficial impact on NAFLD, independent of change in BMI or glucose lowering agent.
Nutr Metab Cardiovasc Dis. 2023 Mar;33(3):640-648. doi: 10.1016/j.numecd.2022.12.010. Epub 2022 Dec 21.

本文引用的文献

1
Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients.
Int J Chron Obstruct Pulmon Dis. 2017 Aug 21;12:2465-2475. doi: 10.2147/COPD.S141295. eCollection 2017.
4
Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan.
Liver Int. 2017 Dec;37(12):1897-1906. doi: 10.1111/liv.13481. Epub 2017 Jul 2.
6
Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease.
World J Hepatol. 2016 Nov 28;8(33):1459-1465. doi: 10.4254/wjh.v8.i33.1459.
7
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
Obes Facts. 2016;9(2):65-90. doi: 10.1159/000443344. Epub 2016 Apr 8.
9
The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.
Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):13-20. doi: 10.1016/j.clinre.2011.08.001. Epub 2011 Sep 15.
10
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验